Literature DB >> 34458925

Antipruritic Effect of Topical Acetaminophen Gel in Histaminergic and Non-histaminergic Itch Provocation: A Double-blind, Vehicle-controlled Pilot Study.

Leigh A Nattkemper1, Kaining Zhi, Kaeli E Romero, Serena M Shah, Teresa Ju, Kayla Fourzali, Rachel Shireen Golpanian, Flor MacQuhae, Yiong Huak Chan, David B Lebo, Gil Yosipovitch.   

Abstract

There is a need for new topical antipruritics that are effective on many types of itch. This study examined the antipruritic efficacy of a new formulation of topical acetaminophen. In vitro skin permeability studies showed that 2.5% and 5% formulations are able to rapidly deliver an adequate amount of the drug into the skin. In a double-blind, vehicle-controlled, randomized study in 17 healthy volunteers, 1%, 2.5% and 5% acetaminophen gels and a vehicle gel were applied to the skin prior to histaminergic and non-histaminergic itch induction and assessment of thermal pain thresholds. The 2.5% and 5% gel formulations significantly reduced the itch intensity time course and the area under the curve for both histamine and cowhage itch. No effect was noted on heat pain thresholds and no adverse effects were observed. These results suggest that topical acetaminophen would be a safe and effective over-the-counter medication for itch.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34458925      PMCID: PMC9558331          DOI: 10.2340/00015555-3910

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  17 in total

1.  The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch.

Authors:  Leigh A Nattkemper; Hong Liang Tey; Rodrigo Valdes-Rodriguez; Helen Lee; Nicholas K Mollanazar; Christian Albornoz; Kristen M Sanders; Gil Yosipovitch
Journal:  J Invest Dermatol       Date:  2018-01-06       Impact factor: 8.551

2.  Subcutaneous administration of paracetamol-Good local tolerability in palliative care patients: An observational study.

Authors:  Benoît F Leheup; Stéphanie Ducousso; Stéphane Picard; Raphaël Alluin; Christophe Goetz
Journal:  Palliat Med       Date:  2018-05-08       Impact factor: 4.762

3.  Polidocanol inhibits cowhage - but not histamine-induced itch in humans.

Authors:  Tomasz Hawro; Joachim W Fluhr; Valérie Mengeaud; Daniel Redoulès; Martin K Church; Marcus Maurer; Martin Metz
Journal:  Exp Dermatol       Date:  2014-12       Impact factor: 3.960

4.  Emerging drugs for the treatment of chronic pruritic diseases.

Authors:  Kayla Fourzali; Rachel Shireen Golpanian; Gil Yosipovitch
Journal:  Expert Opin Emerg Drugs       Date:  2020-08-12       Impact factor: 4.191

5.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

6.  Topically applied aspirin rapidly decreases histamine-induced itch.

Authors:  G Yosipovitch; J Ademola; P Lui; S Amin; H I Maibach
Journal:  Acta Derm Venereol       Date:  1997-01       Impact factor: 4.437

7.  Itch: role of prostaglandins.

Authors:  M W Greaves; W McDonald-Gibson
Journal:  Br Med J       Date:  1973-09-22

8.  A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch.

Authors:  Alexandru D P Papoiu; Rodrigo Valdes-Rodriguez; Leigh A Nattkemper; Yiong-Huak Chan; Gary S Hahn; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2013-09-04       Impact factor: 4.437

9.  Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch.

Authors:  Alexandru D P Papoiu; Hong Liang Tey; Robert C Coghill; Hui Wang; Gil Yosipovitch
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

10.  Reactive metabolites of acetaminophen activate and sensitize the capsaicin receptor TRPV1.

Authors:  Mirjam J Eberhardt; Florian Schillers; Esther M Eberhardt; Linus Risser; Jeanne de la Roche; Christine Herzog; Frank Echtermeyer; Andreas Leffler
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.